Jyotika Singh
Jyotika Singh, senior principal consultant and chair of the HSJ Lung Cancer Panel
HSJ PartnersUnlocking innovation in cancer care: A call to action for system-level change (AstraZeneca sponsored)
At a recent AstraZeneca UK sponsored HSJ roundtable event for NHS stakeholders, I had the privilege of hearing directly from clinicians, digital leads, and operational decision-makers across multiple cancer pathways.
HSJ InteractiveReimagining medicines optimisation: A call to action for reducing health inequalities
Aspire Pharma Ltd initiated and funded this article but had no input into the content and was able to review it in advance of publication for factual accuracy and compliance checks only.
HSJ PartnersIt’s time to optimise medicines optimisation
Working much more collaboratively, with a full range of partners, could improve the use of medicines in the NHS – so saving money and improving care, says Jyotika Singh, principal consultant, Wilmington Healthcare